The HIV-1 Cell Entry Inhibitor T-20 Potently Chemoattracts Neutrophils by Specifically Activating the N-Formylpeptide Receptor
- 1 June 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 272 (3), 699-704
- https://doi.org/10.1006/bbrc.2000.2846
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- N-Formylpeptides Induce Two Distinct Concentration Optima for Mouse Neutrophil Chemotaxis by Differential Interaction with Two N-Formylpeptide Receptor (Fpr) SubtypesThe Journal of Experimental Medicine, 1999
- HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.Journal of Clinical Investigation, 1998
- Differential Expansion of the N-Formylpeptide Receptor Gene Cluster in Human and MouseGenomics, 1998
- HIV Entry and Its InhibitionCell, 1998
- HIV-1 Membrane Fusion Mechanism: Structural Studies of the Interactions between Biologically-Active Peptides from gp41Biochemistry, 1996
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- The Molecular Biology of Leukocyte Chemoattractant ReceptorsAnnual Review of Immunology, 1994
- A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell FusionAIDS Research and Human Retroviruses, 1993
- The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptorsBiochemistry, 1990
- Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1Science, 1987